Literature DB >> 30376607

Identification of Specific and Nonspecific Inhibitors of Bacillus anthracis Type III Pantothenate Kinase (PanK).

Justin A Shapiro1, John J Varga2, Derek Parsonage3, William Walton4, Matthew R Redinbo4, Larry J Ross5, E Lucile White5, Robert Bostwick5, William M Wuest1,6, Al Claiborne3, Joanna B Goldberg2,6.   

Abstract

Antibiotics with novel mechanisms of action are desperately needed to combat the increasing rates of multidrug-resistant infections. Bacterial pantothenate kinase (PanK) has emerged as a target of interest to cut off the biosynthesis of coenzyme A. Herein we report the results of an in vitro high-throughput screen of over 10 000 small molecules against Bacillus anthracis PanK, as well as a follow-up screen of hits against PanK isolated from Pseudomonas aeruginosa and Burkholderia cenocepacia. Nine hits are structurally categorized and analyzed to set the stage for future drug development.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Bacillus; Pseudomonas; antibiotic resistance; high-throughput screening; pantothenate kinase

Mesh:

Substances:

Year:  2018        PMID: 30376607      PMCID: PMC6456334          DOI: 10.1002/cmdc.201800652

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  11 in total

1.  A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site.

Authors:  Lucy Stols; Minyi Gu; Lynda Dieckman; Rosemarie Raffen; Frank R Collart; Mark I Donnelly
Journal:  Protein Expr Purif       Date:  2002-06       Impact factor: 1.650

2.  NIH Molecular Libraries Initiative.

Authors:  Christopher P Austin; Linda S Brady; Thomas R Insel; Francis S Collins
Journal:  Science       Date:  2004-11-12       Impact factor: 47.728

3.  Crystal structure of a type III pantothenate kinase: insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteria.

Authors:  Kun Yang; Yvonne Eyobo; Leisl A Brand; Dariusz Martynowski; Diana Tomchick; Erick Strauss; Hong Zhang
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

4.  Prokaryotic type II and type III pantothenate kinases: The same monomer fold creates dimers with distinct catalytic properties.

Authors:  Bum Soo Hong; Mi Kyung Yun; Yong-Mei Zhang; Shigeru Chohnan; Charles O Rock; Stephen W White; Suzanne Jackowski; Hee-Won Park; Roberta Leonardi
Journal:  Structure       Date:  2006-08       Impact factor: 5.006

5.  Structure of the type III pantothenate kinase from Bacillus anthracis at 2.0 A resolution: implications for coenzyme A-dependent redox biology.

Authors:  Nathan I Nicely; Derek Parsonage; Carleitta Paige; Gerald L Newton; Robert C Fahey; Roberta Leonardi; Suzanne Jackowski; T Conn Mallett; Al Claiborne
Journal:  Biochemistry       Date:  2007-02-27       Impact factor: 3.162

6.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

Review 7.  Coenzyme A biosynthesis: an antimicrobial drug target.

Authors:  Christina Spry; Kiaran Kirk; Kevin J Saliba
Journal:  FEMS Microbiol Rev       Date:  2008-01       Impact factor: 16.408

8.  Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections.

Authors:  Anthony E Choudhry; Tracy L Mandichak; John P Broskey; Richard W Egolf; Cynthia Kinsland; Tadhg P Begley; Mark A Seefeld; Thomas W Ku; James R Brown; Magdalena Zalacain; Kapila Ratnam
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Structural basis for substrate binding and the catalytic mechanism of type III pantothenate kinase.

Authors:  Kun Yang; Erick Strauss; Carlos Huerta; Hong Zhang
Journal:  Biochemistry       Date:  2008-01-11       Impact factor: 3.162

10.  Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves
Journal:  Int Arch Med       Date:  2008-11-07
View more
  1 in total

Review 1.  Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.

Authors:  Manish T Shrivastav; Zainab Malik
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.